Filed with the SEC on · accession 0001493152-26-042854
CODX filed a 8-K (current report) with the SEC on Sep 16, 2026. A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The stock moved -17.5% by the first close after the filing.
Co-Diagnostics, Inc. furnished an investor and analyst presentation covering its collaboration with ReadyGo Diagnostics Ltd., its Co-Dx PCR platform development, manufacturing initiatives, and India operations.
Close before
$1.14
Sep 15, 2026
First close after
-17.47%
$0.94
5 trading days
-5.26%
$1.08
Since filing
-77.47%
$0.26
✦ Ask GOAX AI about this filing — what it means for CODX, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for CODX?
Click hereCODX filed a 8-K (SEC filing). Co-Diagnostics, Inc. furnished an investor and analyst presentation covering its collaboration with ReadyGo Diagnostics Ltd., its Co-Dx PCR platform development, manufacturing initiatives, and India operations.
A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
CODX closed at $1.14 before the filing and $0.94 on Sep 16, 2026 (-17.47%). Five trading days later: $1.08 (-5.26%).
Get alerts when CODX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days